Announcement

Collapse
No announcement yet.

Welcome to our forum! Before posting your questions, please read the following terms:

  1. 1. Forum questions will be responded to by InfantRisk staff as schedules permit during normal business hours.
  2. 2. This forum is not intended for emergencies or urgent care. For any immediate medical concerns, please seek appropriate medical attention.
  3. 3. Any statements made by team members should be discussed with your medical care team. Your healthcare providers know you (and your baby) best, and should have a better understanding of your unique situation.
  4. 4. We are a small team dedicated to helping you as best as we can. However, for the quickest response, we recommend calling the InfantRisk Center at +1(806) 352-2519.

By posting to the forums, you acknowledge and agree to these terms.

The InfantRisk team

Tovias and breastfeeding

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Tovias and breastfeeding

    i have a lady who during pregnancy was told not to take this medictaion (she is taking always for urine incompetancy). She is planning to breastfeed and we cannot find any information about Tovias and breastfeeding.
    I will be happy to get youre opinion.
    Thank you
    Orli Amram
    Israel

  • #2
    Dear Orli,

    Fesoterodine (Toviaz) is an anti-muscarinic agent, it is rapidly metabolized in vivo to produce its active metabolite tolterodine. Tolterodine is a muscarinic anticholinergic agent similar in effect to atropine but is more selective for the urinary bladder. Tolterodine levels in milk have been reported in mice, where offsprings exposed to extremely high levels had slightly reduced body weight gain, but no other untoward effects. While we have no data on human milk, it is unlikely concentrations will be high enough to produce untoward effects in infants. However, the infant should be monitored for classic anticholinergic symptoms including dry mouth, constipation, poor tearing, etc.

    Tassneem Abdel Karim, MD
    InfantRisk Center

    Comment

    Working...
    X